Navidea Biopharmaceuticals, Inc. Skyrocketed
Mon, Feb 07, 2022 at 05:30 PM
Navidea Biopharmaceuticals, Inc. (NAVB:NYSEMKT) jumped higher at $0.89, a gain of 23.2%. On Thu, Feb 03, 2022, NAVB:NYSEMKT touched a New 2-Week Low of $0.94. The stock got featured on our News Catalysts scanner on Mon, Feb 07, 2022 at 09:16 AM in the 'AGREEMENT' category. From Thu, Jan 20, 2022, the stock recorded 40.00% Up Days and 45.45% Green Days
The share price of the company has been moving sideways in recent weeks.
About Navidea Biopharmaceuticals, Inc. (NAVB:NYSEMKT)
Navidea Biopharmaceuticals Inc is a biotechnology company engaged in precision medicine. Its products are designed to assist in the identification of undetected diseases and develop treatment for cancer, autoimmune conditions, and inflammatory diseases.
Top 10 Gainers:
- Nuvectis Pharma Inc. (NVCT:NASDAQ), 144.62%
- Anghami Inc. (ANGH:NASDAQ), 62.5%
- Origin Agritech Limited (SEED:NASDAQ), 34.53%
- Bakkt Holdings Inc. Class A (BKKT:NYSE), 33.95%
- Luokung Technology Corp. (LKCO:NASDAQ), 24.31%
- Navidea Biopharmaceuticals, Inc. (NAVB:NYSEMKT), 23.19%
- Peloton Interactive, Inc. (PTON:NASDAQ), 20.94%
- Castor Maritime Inc. (CTRM:NASDAQ), 20.25%
- Synthetic Biologics, Inc. (SYN:NYSEMKT), 19.99%
- ContraFect Corporation (CFRX:NASDAQ), 18.18%